SCHEMBL3268748

SCHEMBL3268748

CC(C)(C)OC(=O)N1CCN(c2ccnc(-c3ccccc3)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 2/20 0.56
SKP1 P63208 2/20 0.56
SKP2 Q13309 2/20 0.56
KIT P10721 2/20 0.53
ABCB1 P08183 1/20 0.52
ABCG2 Q9UNQ0 1/20 0.52
GPR119 Q8TDV5 4/20 0.52
ACHE P22303 1/20 0.52
PIK3CA P42336 1/20 0.52
PDK2 Q15119 1/20 0.50
ADORA2A P29274 1/20 0.49
GBA1 P04062 1/20 0.49
ALK Q9UM73 1/20 0.49
JAK2 O60674 1/20 0.48
JAK3 P52333 1/20 0.48
SMARCA2 P51531 1/20 0.48
SMARCA4 P51532 1/20 0.48
PBRM1 Q86U86 1/20 0.48
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2014735 0.83 WNT3A (0.46) CKS1BSKP1SKP2GPR119ACHE
SCHEMBL21274054 0.82 MAPT (0.55) CKS1BSKP1SKP2GPR119PDK2
SCHEMBL3060483 0.82 CKS1B (0.60) CKS1BSKP1SKP2KITABCB1
SCHEMBL13164532 0.82 GPR119 (0.61) CKS1BSKP1SKP2KITGPR119
SCHEMBL10320809 0.82 WNT3A (0.56) CKS1BSKP1SKP2GPR119ACHE
SCHEMBL194454 0.82 MAPT (0.53) CKS1BSKP1SKP2GPR119ACHE
SCHEMBL3274585 0.81 ACHE (0.66) CKS1BSKP1SKP2KITABCB1
SCHEMBL3273530 0.81 CKS1B (0.62) CKS1BSKP1SKP2KITABCB1
SCHEMBL20516341 0.81 ADORA2A (0.53) CKS1BSKP1SKP2KITABCB1
SCHEMBL30791110 0.81 ADORA2A (0.53) CKS1BSKP1SKP2KITABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101981010-A Amide compound TAKEDA PHARMACEUTICAL 2011-02-23 CN disclosed
US-20100234389-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed
EP-2199282-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2010-06-23 EP disclosed
US-20090163508-A1 AMIDE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234389-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA CKS1B 3175/4885SKP1 3469/4885SKP2 3535/4885
US-20090163508-A1 AMIDE COMPOUND FAAH, FAAH2, NAAA CKS1B 3175/4885SKP1 3469/4885SKP2 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.